To include your compound in the COVID-19 Resource Center, submit it here.

Biogen agrees to outcomes-based contract for MS portfolio

Biogen Inc. (NASDAQ:BIIB) signed an outcomes-based contract with PBM Prime Therapeutics LLC (Eagan, Minn.)

Read the full 143 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE